Altogen Biosystems Announced Its in Vivo Nanoparticle-Based Transfection Reagent is Effective in Brain-Targeted Drug Delivery and Capable of Overcoming Blood-Brain Barrier
Altogen Biosystems, leading manufacturer of in vivo transfection products, announced today that Altogen’s nanoparticle-based in vivo Transfection reagent (product catalog #5031) was demonstrated to be effective for glioblastoma-targeted co-delivery of plasmid DNA (3.7kb) and chemically modified siRNA. This transfection reagent was used in over 30 research publications, demonstrating highly efficient delivery of cargo nucleic acids to the following tissues: lung, liver, … Read more